🔓 Unlock the full profile of Jeffery Schipper (Restech), including verified contact details, financial insights, and professional associations.
See Jeffery Schipper Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: jef*****@res******.com
Mobile: 98096*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Jeffery Schipper co-founded Restech in 2003, aiming to address issues related to gastroesophageal reflux disease (GERD) through innovative medical technology.
- As Director of Restech, Schipper contributed to the development of the company's flagship product, which focused on providing accurate diagnostics for reflux conditions.
- Prior to Restech, Schipper served as CEO of Sierra Medical Technology, Inc. from 1998, where leadership skills were honed in a fast-paced medical environment.
- Schipper’s experience includes a role as VP Operations at Restech from 2011 to 2015, overseeing operational strategies and ensuring effective project implementation.
- From 1997 to 1998, Schipper was VP Engineering & Quality at Navius Corporation, facilitating advancements in engineering processes within the medical field.
- Earlier experience includes serving as VP R&D at IMED/Alaris Medical from 1991 to 1996, contributing to research and development efforts that advanced medical device technologies.
- Restech, under Schipper’s leadership, has faced challenges such as market competition and technological advancements, requiring constant innovation and adaptation.
- Despite fluctuations, Restech has maintained a commitment to research and development, seeking to improve the quality of life for those suffering from reflux-related disorders.
- With a focus on growth, Restech experienced a decline in headcount over recent years, prompting strategic reevaluations and a focus on sustainable practices.
- Schipper’s journey illustrates a profound dedication to the medical technology sector, emphasizing the importance of innovation, patient care, and operational excellence.